165 related articles for article (PubMed ID: 17273549)
21. Triiodothyronine administration ameliorates the demyelination/remyelination ratio in a non-human primate model of multiple sclerosis by correcting tissue hypothyroidism.
D'Intino G; Lorenzini L; Fernandez M; Taglioni A; Perretta G; Del Vecchio G; Villoslada P; Giardino L; Calzà L
J Neuroendocrinol; 2011 Sep; 23(9):778-90. PubMed ID: 21707794
[TBL] [Abstract][Full Text] [Related]
22. Interferon-gamma protects against cuprizone-induced demyelination.
Gao X; Gillig TA; Ye P; D'Ercole AJ; Matsushima GK; Popko B
Mol Cell Neurosci; 2000 Oct; 16(4):338-49. PubMed ID: 11085872
[TBL] [Abstract][Full Text] [Related]
23. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
[TBL] [Abstract][Full Text] [Related]
24. The role of stress-response systems for the pathogenesis and progression of MS.
Gold SM; Mohr DC; Huitinga I; Flachenecker P; Sternberg EM; Heesen C
Trends Immunol; 2005 Dec; 26(12):644-52. PubMed ID: 16214415
[TBL] [Abstract][Full Text] [Related]
25. Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review.
Heesen C; Gold SM; Huitinga I; Reul JM
Psychoneuroendocrinology; 2007 Jul; 32(6):604-18. PubMed ID: 17602841
[TBL] [Abstract][Full Text] [Related]
26. [Experimental autoimmune encephalomyelitis].
Cornet A; Vizler C; Liblau R
Rev Neurol (Paris); 1998 Sep; 154(8-9):586-91. PubMed ID: 9809373
[TBL] [Abstract][Full Text] [Related]
27. The effects of interferon-gamma on the central nervous system.
Popko B; Corbin JG; Baerwald KD; Dupree J; Garcia AM
Mol Neurobiol; 1997; 14(1-2):19-35. PubMed ID: 9170099
[TBL] [Abstract][Full Text] [Related]
28. PPARgamma antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis.
Raikwar HP; Muthian G; Rajasingh J; Johnson C; Bright JJ
J Neuroimmunol; 2005 Oct; 167(1-2):99-107. PubMed ID: 16091293
[TBL] [Abstract][Full Text] [Related]
29. Idazoxan attenuates spinal cord injury by enhanced astrocytic activation and reduced microglial activation in rat experimental autoimmune encephalomyelitis.
Wang XS; Chen YY; Shang XF; Zhu ZG; Chen GQ; Han Z; Shao B; Yang HM; Xu HQ; Chen JF; Zheng RY
Brain Res; 2009 Feb; 1253():198-209. PubMed ID: 19083996
[TBL] [Abstract][Full Text] [Related]
30. The pathology of multiple sclerosis and its evolution.
Lassmann H
Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1635-40. PubMed ID: 10603616
[TBL] [Abstract][Full Text] [Related]
31. Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis.
Brosnan CF; Selmaj K; Raine CS
J Neuroimmunol; 1988 Apr; 18(1):87-94. PubMed ID: 3257971
[No Abstract] [Full Text] [Related]
32. An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells.
Hwang I; Ahn G; Park E; Ha D; Song JY; Jee Y
Immunol Lett; 2011 Aug; 138(2):169-78. PubMed ID: 21524666
[TBL] [Abstract][Full Text] [Related]
33. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
34. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
Raine CS
Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955
[No Abstract] [Full Text] [Related]
35. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
[TBL] [Abstract][Full Text] [Related]
36. Poly(ADP-ribose) polymerase-1 activation in a primate model of multiple sclerosis.
Kauppinen TM; Suh SW; Genain CP; Swanson RA
J Neurosci Res; 2005 Jul; 81(2):190-8. PubMed ID: 15931673
[TBL] [Abstract][Full Text] [Related]
37. Primary demyelination in transgenic mice expressing interferon-gamma.
Horwitz MS; Evans CF; Mcgavern DB; Rodriguez M; Oldstone MBA
Nat Med; 1997 Sep; 3(9):1037-1041. PubMed ID: 9288735
[TBL] [Abstract][Full Text] [Related]
38. Oligodendroglial response to the immune cytokine interferon gamma.
Popko B; Baerwald KD
Neurochem Res; 1999 Feb; 24(2):331-8. PubMed ID: 9972883
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis.
Patel J; Balabanov R
Int J Mol Sci; 2012; 13(8):10647-10659. PubMed ID: 22949885
[TBL] [Abstract][Full Text] [Related]
40. Introduction and comments: myelination and demyelination.
Einstein ER
Adv Exp Med Biol; 1978; 100():1-16. PubMed ID: 80934
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
